A free public lecture on what we’re learning about how cancer travels through the body, and the pros and cons of tailoring specific treatments for each patient, part of a series of presentations on cancer prevention and treatment sponsored by the Cancer Therapy & Research Center at The University of Texas Health Science Center
6 – 7:30 p.m. Thursday, April 12, 2012
CTRC, 7979 Wurzbach, 4th Floor Grossman Building, San Antonio
Tim Huang, Ph.D., deputy director of the CTRC, will explain the cutting-edge research that is beginning to unlock the puzzle of metastasis.
Steven Dale Weitman, M.D., Ph.D., director of the Institute for Drug Development at the CTRC, will discuss developing specific cancer treatments based on the genetic makeup, or signature, of an individual’s cancer.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.